Blake Borgeson, a director at Recursion Pharmaceuticals (NASDAQ:RXRX), sold 30,000 shares of the company’s Class A Common Stock on August 4, 2026, for a total value of $97,500.
what a traitor to the cause!
what a traitor to the cause!
who here has lost weight using the diarrhea lettuce and increased their VAM?
it must be hard to sell these types of unusual renovations
Dinler picked up the victim from partying and got angry she threw up in his car. He then followed her back to her room and raped her. He then returned and demanded the victim Venmo him money for throwing up in his car.
His lawyer initially tried to argue on the defense that she called her friends about the situation before calling the police, but ultimately pleaded no contest after DNA evidence put him in a no-win situation.
Sentencing is scheduled for October.
I don't think Recursion got much benefit from AI, at least the ML-oriented AI they started with. Their pipeline is unremarkable. Now that LLM-oriented AI could help accelerate drug development, they no longer have any first mover advantage.
Had two visits with two different cats where the technician was unable to do blood draws and sent us home with gabapentin to sedate our cats for a follow up.
They seem ok with our dogs.
Please tell us:
- how many hours a week were spent doing RA/TA work or work for other people's papers, whether this was a formalized number of hours on contract or not
- field
- institution (R1, R2, LAC, other)
I'm not seeing a big drop off in price per sqft as you get closer to this arsenic laden hole.